KIG
PBYI icon

Kessler Investment Group’s Puma Biotechnology PBYI Stock Holding History

Kessler Investment Group’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-27,127
Closed -$1.01M – 101
2017
Q1 		$1.01M Buy
27,127
+7,338
+37% +$268K 1.29% 22
2016
Q4 		$608K Buy
19,789
+1,653
+9% +$71.5K 0.73% 29
2016
Q3 		$1.22M Buy
+18,136
New +$917K 1.76% 21

Other funds holding PBYI

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Kessler Investment Group's PBYI Position: Q2 2017 in Review

Kessler Investment Group sold out of Puma Biotechnology (PBYI) in Q2 2017, closing a stake of 27,127 shares — an estimated $1.01M sold.

Kessler Investment Group first reported a position in PBYI in Q3 2016 and held it in 3 quarters. The position peaked at $1.22M in Q3 2016. 154 funds tracked by Wall St. Rank hold PBYI as of Q2 2017.

  • Kessler Investment Group reported no remaining Puma Biotechnology position as of Q2 2017 after selling out during the quarter.
  • Kessler Investment Group sold 27,127 Puma Biotechnology shares in Q2 2017, an estimated $1.01M.
  • Kessler Investment Group first reported a position in Puma Biotechnology in Q3 2016 and held it in 3 quarters.
  • Kessler Investment Group's Puma Biotechnology position peaked at $1.22M in Q3 2016.
  • 154 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2017.

Based on Kessler Investment Group's 13F filing for Q2 2017, filed 19 Jul 2017.